Prognostic factors for atherosclerosis progression in saphenous vein grafts: the postcoronary artery bypass graft (Post-CABG) trial. Post-CABG Trial Investigators.
暂无分享,去创建一个
N L Geller | B. Hoogwerf | C. White | M. Domanski | N. Geller | Y. Rosenberg | G. Knatterud | L. Campeau | C. Borkowf | M J Domanski | Y Rosenberg | G L Knatterud | C B Borkowf | L Campeau | C White | B Hoogwerf
[1] L. Campeau,et al. Late thrombosis of saphenous vein coronary bypass grafts related to risk factors. , 1988, Circulation.
[2] A. Voors,et al. Venous Coronary Artery Bypass Surgery A 15‐Year Follow‐up Study , 1993, Circulation.
[3] M. Bourassa. Fate of venous grafts: the past, the present and the future. , 1991, Journal of the American College of Cardiology.
[4] D H Blankenhorn,et al. Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts. , 1987, JAMA.
[5] E. Jones,et al. Frequency of repeat coronary bypass or coronary angioplasty after coronary artery bypass surgery using saphenous venous grafts. , 1994, The American journal of cardiology.
[6] V. Fuster,et al. A platelet-inhibitor-drug trial in coronary-artery bypass operations: benefit of perioperative dipyridamole and aspirin therapy on early postoperative vein-graft patency. , 1982, The New England journal of medicine.
[7] Post Coronary Artery Bypass Graft Trial Investigators. The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts. , 1997, The New England journal of medicine.
[8] R. Virmani,et al. Morphologie Changes in Long-term Saphenous Vein Bypass Grafts , 1985 .
[9] G. Beck,et al. Serum Lp(a) level as a predictor of vein graft stenosis after coronary artery bypass surgery in patients. , 1988, Circulation.
[10] W J Keon,et al. Coronary bypass graft fate and patient outcome: angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years. , 1996, Journal of the American College of Cardiology.
[11] S. Zeger,et al. Longitudinal data analysis using generalized linear models , 1986 .
[12] T. Chalmers,et al. Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration , 1994, The Lancet.
[13] G. Fitzgibbon,et al. Atherosclerosis of coronary artery bypass grafts and smoking. , 1987, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[14] J. Barboriak,et al. Atherosclerosis in aortocoronary bypass grafts. Morphologic study and risk factor analysis 6 to 12 years after surgery. , 1986, Arteriosclerosis.
[15] H. Daida,et al. Relation of saphenous vein graft obstruction to serum cholesterol levels. , 1995, Journal of the American College of Cardiology.
[16] H. Barnhart,et al. Goodness-of-fit tests for GEE modeling with binary responses. , 1998, Biometrics.
[17] L. Campeau,et al. Pathologic changes in coronary artery saphenous vein grafts and related etiologic factors. , 1991, Cardiovascular clinics.
[18] E J Topol,et al. Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention. , 1998, Circulation.
[19] L. Campeau,et al. Risk factors of venous aortocoronary bypass graft disease noted at late symptom-directed angiographic study. , 1993, The Canadian journal of cardiology.
[20] E. E. Campos,et al. Long-term angiographic follow-up of normal and minimally diseased saphenous vein grafts. , 1993, Journal of the American College of Cardiology.
[21] N L Geller,et al. Aggressive cholesterol lowering delays saphenous vein graft atherosclerosis in women, the elderly, and patients with associated risk factors. NHLBI post coronary artery bypass graft clinical trial. Post CABG Trial Investigators. , 1999, Circulation.
[22] M. Bourassa,et al. Atherosclerosis and late closure of aortocoronary saphenous vein grafts: sequential angiographic studies at 2 weeks, 1 year, 5 to 7 years, and 10 to 12 years after surgery. , 1983, Circulation.
[23] Alan Agresti,et al. Categorical Data Analysis , 1991, International Encyclopedia of Statistical Science.
[24] F. Loop,et al. Predictors of reoperation after myocardial revascularization. , 1986, The Journal of thoracic and cardiovascular surgery.
[25] R. Hoffmann,et al. Risk factors among patients undergoing repeat aorta-coronary bypass procedures. , 1987, The Journal of thoracic and cardiovascular surgery.
[26] S. Wacholder,et al. The relation of risk factors to the development of atherosclerosis in saphenous-vein bypass grafts and the progression of disease in the native circulation. A study 10 years after aortocoronary bypass surgery. , 1984, The New England journal of medicine.
[27] G. Lawrie,et al. Aortocoronary bypass saphenous vein graft atherosclerosis. Anatomic study of 99 vein grafts from normal and hyperlipoproteinemic patients up to 75 months postoperatively. , 1977, The American journal of cardiology.
[28] S. Azen,et al. Beneficial effects of colestipol-niacin on coronary atherosclerosis. A 4-year follow-up. , 1990, JAMA.
[29] B. Chaitman,et al. Comparison of 15-year survival for men and women after initial medical or surgical treatment for coronary artery disease: a CASS registry study. Coronary Artery Surgery Study. , 1995, Journal of the American College of Cardiology.
[30] R. Virmani,et al. Morphologic changes in long-term saphenous vein bypass grafts. , 1985, Chest.